KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to -$449.9 million.

  • Astrana Health's Enterprise Value rose 1862.03% to -$449.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$449.9 million, marking a year-over-year increase of 1862.03%. This contributed to the annual value of -$286.8 million for FY2024, which is 239.73% up from last year.
  • Per Astrana Health's latest filing, its Enterprise Value stood at -$449.9 million for Q3 2025, which was up 1862.03% from -$336.1 million recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Enterprise Value peaked at -$159.0 million during Q1 2021, and registered a low of -$552.9 million during Q3 2024.
  • Over the past 5 years, Astrana Health's median Enterprise Value value was -$264.4 million (recorded in 2023), while the average stood at -$306.9 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 29210.66% in 2021, then skyrocketed by 5286.98% in 2025.
  • Astrana Health's Enterprise Value (Quarter) stood at -$230.0 million in 2021, then decreased by 21.47% to -$279.4 million in 2022, then fell by 5.2% to -$293.9 million in 2023, then increased by 2.4% to -$286.8 million in 2024, then plummeted by 56.86% to -$449.9 million in 2025.
  • Its Enterprise Value was -$449.9 million in Q3 2025, compared to -$336.1 million in Q2 2025 and -$255.8 million in Q1 2025.